Targeting the Interaction between the SH3 Domain of Grb2 and Gab2

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Gab2 is an overexpressed scaffolding protein implicated in cancer cell proliferation, migration, and differentiation.
• The interaction between Gab2 and the Grb2 C-terminal SH3 domain is vital for Ras/Erk pathway activation, a key target in cancer therapy.

Purpose of the Study:

• To identify potential inhibitors of the Gab2-Grb2 interaction.
• To validate the efficacy of identified inhibitors in cancer cell lines.

Main Methods:

• Virtual screening was employed to identify potential inhibitor molecules.
• Kinetic and equilibrium binding experiments were conducted for experimental testing.
• In vitro validation was performed using A549 and H1299 lung cancer cell lines.

Main Results:

• Seven potential inhibitor molecules were identified through virtual screening.
• One compound significantly reduced the binding affinity between the Grb2 C-SH3 domain and Gab2.
• The inhibitory effect was confirmed in lung cancer cell lines.

Conclusions:

• A novel compound effectively inhibits the Gab2-Grb2 interaction.
• This finding offers a potential therapeutic strategy for cancers overexpressing Gab2.
• Further research into this compound could lead to new anti-cancer drug development.